Hongqun Liu

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Atrial Fibrillation

Percutaneous Coronary Intervention

Angiotensin Converting Enzyme

Acute Heart Failure

Top Venues

Alimentary pharmacology & therapeutics

International journal of molecular sciences

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Hongqun Liu, Dae-Gon Ryu, Sang Youn Hwang, Samuel S Lee
Therapies for Cirrhotic Cardiomyopathy: Current Perspectives and Future Possibilities. International journal of molecular sciences 25 (11) (2024)
Hongqun Liu, Dae-Gon Ryu, Sang Youn Hwang, Samuel S Lee
Therapies for Cirrhotic Cardiomyopathy: Current Perspectives and Future Possibilities. International journal of molecular sciences 25 (11) (2024)
Sang Youn Hwang, Hongqun Liu, Samuel S Lee
Dysregulated Calcium Handling in Cirrhotic Cardiomyopathy. Biomedicines 11 (7) (2023)
Hongqun Liu, Sang Youn Hwang, Samuel S Lee
Role of Galectin in Cardiovascular Conditions including Cirrhotic Cardiomyopathy. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Bert Vandenberk, Mario H Altieri, Hongqun Liu, Satish R Raj, Samuel S Lee
Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension. Alimentary pharmacology & therapeutics 57 (3) (2022)
Bert Vandenberk, Mario H Altieri, Hongqun Liu, Satish R Raj, Samuel S Lee
Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension. Alimentary pharmacology & therapeutics 57 (3) (2022)
Bert Vandenberk, Mario H Altieri, Hongqun Liu, Satish R Raj, Samuel S Lee
Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension. Alimentary pharmacology & therapeutics 57 (3) (2022)
Bert Vandenberk, Mario H Altieri, Hongqun Liu, Satish R Raj, Samuel S Lee
Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension. Alimentary pharmacology & therapeutics (2022)
Bert Vandenberk, Mario H Altieri, Hongqun Liu, Satish R Raj, Samuel S Lee
Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension. Alimentary pharmacology & therapeutics 57 (3) (2022)
Daljeet Chahal, Hongqun Liu, Chris Shamatutu, Hasrit Sidhu, Samuel S Lee, Vladimir Marquez
Review article: comprehensive analysis of cirrhotic cardiomyopathy. Alimentary pharmacology & therapeutics 53 (9) (2021)
Lixia Ma, Xiaohui Liu, Qingshan Wu, Xing Hu, Hongqun Liu, Jing Zhang, Samuel S Lee
Role of Anti-Beta-1-Adrenergic Receptor Antibodies in Cardiac Dysfunction in Patients with Cirrhotic Cardiomyopathy. Journal of cardiovascular translational research (2021)
Hooman Honar, Hongqun Liu, Mei L Zhang, Tamara K Glenn, Henk E D J Ter Keurs, Samuel S Lee
Impaired myosin isoform shift and calcium transients contribute to cellular pathogenesis of rat cirrhotic cardiomyopathy. Liver international : official journal of the International Association for the Study of the Liver 40 (11) (2020)
Mark G Swain, John L Wallace, D Lorne Tyrrell, José Cabanillas, Steven K H Aung, Hongqun Liu, Lindsay Finnie-Carvalho, Grishma Shrestha, Hugh A Semple, Francis H Y Green
Efficacy of a Peruvian Botanical Remedy (Sabell A4+) for Treating Liver Disease and Protecting Gastric Mucosal Integrity. Evidence-based complementary and alternative medicine : eCAM 2019 (2019)